首页> 美国卫生研究院文献>BMC Public Health >Efficacy of indoor air purification in treating Artemisia (mugwort) pollen allergic rhinitis: study protocol for a randomised controlled trial
【2h】

Efficacy of indoor air purification in treating Artemisia (mugwort) pollen allergic rhinitis: study protocol for a randomised controlled trial

机译:室内空气净化治疗艾蒿(艾蒿)花粉过敏性鼻炎的功效:一项随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAllergic rhinitis (AR) is a worldwide health problem. Allergen avoidance is strongly recommended for AR patients. Air purification can reduce concentrations of particles in indoor air, including those of allergens. Air purifiers have been recommended by clinicians for AR patients, but few studies have focused on the removal of airborne allergens from home environments. Such studies have been limited by a lack of blinding, small samples, or a failure to measure allergen levels, disease activity, or a combination of these factors. This study investigates the efficacy of a high-efficiency air purifier in reducing disease activity in the homes of AR patients sensitive to the allergens produced by Artemisia (mugwort) pollen.
机译:背景过敏性鼻炎(AR)是一个全球性的健康问题。强烈建议AR患者避免使用过敏原。空气净化可以降低室内空气中包括过敏原在内的颗粒浓度。临床医生已经为AR患者推荐了空气净化器,但是很少有研究集中在从家庭环境中去除空气中的过敏原。由于缺乏致盲性,样本量小或无法测量变应原水平,疾病活动性或这些因素的组合,此类研究受到了限制。这项研究调查了一种高效空气净化器在降低对蒿蒿花粉产生的过敏原的AR患者家中疾病活动中的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号